Bridget Charbonneau

发表

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Sebastian M. Armasu, Yurii B. Shvetsov, A. Whittemore, 2013, Nature Communications.

Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer.

Jeremy Chien, Marina Bibikova, Sebastian M. Armasu, 2014, Cancer research.

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

David N. Rider, A. Whittemore, L. Kiemeney, 2014, Cancer research.

DNA Topology and the Initiation of Virus DNA Packaging

J. Sippy, M. Feiss, R. Sippy, 2016, PloS one.

Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

Claudia C. Preston, David N. Rider, A. Whittemore, 2014, Cancer Immunology Research.

The immune system in the pathogenesis of ovarian cancer.

E. Goode, M. DeRycke, K. Knutson, 2013, Critical reviews in immunology.

Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer.

B. Fridley, E. Goode, L. Hartmann, 2014, Cancer Research.

Toward understanding the genetics of regulatory T cells in ovarian cancer

Claudia C. Preston, E. Goode, M. DeRycke, 2013, Oncoimmunology.

T‐cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction

R. Matusik, J. Hayball, Bridget Charbonneau, 2006, The Prostate.

Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells

R. Matusik, T. Ratliff, Bridget Charbonneau, 2006, Immunology.

trans Fatty Acid Intake Is Associated with Increased Risk and n3 Fatty Acid Intake with Reduced Risk of Non-Hodgkin Lymphoma 1–3

J. Cerhan, T. Habermann, S. Slager, 2013 .

Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist1

T. Ratliff, A. Weinberg, Bridget Charbonneau, 2007, The Journal of Immunology.

This information is current as Addition of an OX 40 Agonist or Soluble Antigen Can Be Overcome by the Effector Function after Priming with Tumor Defects in the Acquisition of CD 8 T Cell

T. Ratliff, A. Weinberg, Bridget Charbonneau, 2007 .

An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate

D. Meyerholz, R. Svensson, T. Ratliff, 2011, The Prostate.

CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis

J. Cerhan, Y. Asmann, A. Feldman, 2013, Cancer Immunology, Immunotherapy.

Prostate inflammation and its potential impact on prostate cancer: A current review

T. Ratliff, Bridget Charbonneau, Jessica M. Haverkamp, 2008, Journal of cellular biochemistry.

Germline variation in complement genes and event‐free survival in follicular and diffuse large B‐cell lymphoma

J. Cerhan, T. Habermann, S. Slager, 2012, American journal of hematology.

Ovarian cancer risk associated with inherited inflammation-related variants.

Brooke L. Fridley, Michael J. Birrer, Honglin Song, 2012, Cancer research.

Radiation Oncology 4-10-2012 alpha ( V ) beta ( 6 ) integrin expression is induced in the POET and Pten ( pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma

Chun-Peng Liao, G. Stein, J. Lian, 2017 .

α(V)β(6) integrin expression is induced in the POET and Pten(pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma.

Chun-Peng Liao, G. Stein, J. Lian, 2012, American journal of translational research.

A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab

R. Burge, A. Blauvelt, B. Lockshin, 2022, Dermatology and Therapy.

Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma.

D. Largaespada, Subbaya Subramanian, A. Rizzardi, 2013, Human pathology.

Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma.

J. Cerhan, T. Habermann, S. Slager, 2013, The Journal of nutrition.

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005

S. Ognjanovic, J. Ross, Bridget Charbonneau, 2009, Cancer.

26648 Real-world comparison of monotherapy and concomitant medication use with biologic therapies for psoriasis: Ixekizumab versus guselkumab

R. Burge, A. Blauvelt, B. Lockshin, 2021 .

Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.

J. Cerhan, T. Habermann, S. Slager, 2012, Cytokine.

Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome

A. Whittemore, M. Pike, M. Beckmann, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Dangling the carrot of improved survival in non-Hodgkin lymphoma: does carotenoid consumption make a difference?

Bridget Charbonneau, 2013, Leukemia & lymphoma.

Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

Hannah Yang, James Paul, Honglin Song, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Variation in NFk B Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

Brooke, Tanja, David N. Rider, 2014 .

Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

David N. Rider, A. Whittemore, M. Pike, 2014, Cancer Epidemiology, Biomarkers & Prevention.